News | EP Mapping and Imaging Systems | August 17, 2020

Northwestern Medicine One of First to Use Dielectric Imaging System to Guide Cardiac Ablation

System reduces radiation exposure, provides 3-D, high-definition images of heart in real time


August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in Illinois to use a new advanced imaging system during cryo-ablation for atrial fibrillation. 

The Philips’ Kodex-EPD system uses dielectric imaging to creates 3-D, high-definition images of a patient’s cardiac structures in real time. A completely new approach to imaging the heart, dielectric imaging offers many benefits in comparison to current approaches, for both cryo and radiofrequency ablation procedures. The technology provides real-time 3-D imaging, reducing the need for X-ray imaging and radiation exposure.

Bradley Knight, M.D., medical director of cardiac electrophysiology at Northwestern Memorial Hospital, was one of the first in the country to use the Phillips Kodex-EPD system. The system offered 3-D, high-definition images of a patient’s heart, during an atrial fibrillation (AFib) ablation procedure Aug. 5, 2020.

“I was impressed that this completely new three-dimensional mapping system, which acts much like a GPS system, can accurately and quickly re-create the anatomy of the cardiac chamber of interest and display the heart’s electrical activity using any electrode pairs placed in the heart,” Knight said.

In cryoablation, imaging is critical to help the physician guide the catheter. 

“As the population ages more Americans are being diagnosed with AFib,” said Knight, who is also the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine. “We are always looking for the safest, most advanced treatments for our heart rhythm patients and I was pleased to partner on this new technology.”

The Kodex-EDP system has both FDA 510(k) clearance and European CE mark.

Northwestern Medicine’s Bluhm Cardiovascular Institute is one of the top 10 national programs for cardiology and heart surgery, according to U.S. News and World Report, and ranked the top cardiovascular program in Illinois and the surrounding states for more than 10 consecutive years. 

More than 6 million Americans may have AFib, a heart rhythm disorder when the upper and lower chambers of the heart beat out of synch, either too slowly, too quickly or simply irregularly. Symptoms can include heart palpitations, extreme fatigue, chest pain or shortness of breath, though some with AFib experience no symptoms.

A major risk of AFib is stroke, and one in seven strokes is attributed to AFib.

For more information: news.nm.org/about-northwestern-medicine.html

 

Related Kodex-EPD Dielectric Imaging System Content:

4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
 


Related Content

News | Atrial Fibrillation

Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...

Home November 19, 2024
Home
News | Atrial Fibrillation

Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm ...

Home October 21, 2024
Home
News | Atrial Fibrillation

Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San ...

Home September 11, 2024
Home
News | Atrial Fibrillation

July 24, 2024 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
News | Atrial Fibrillation

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
News | Atrial Fibrillation

June 12, 2024 — A team of Ochsner Health cardiologists recently published an article in the Journal of the American ...

Home June 12, 2024
Home
News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
Subscribe Now